Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs

Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs

Background. To explore clinical characteristics and treatment reasons for intravitreal injection of antivascular endothelial growth factor (anti-VEGF) drugs in the treatment of nontype 1 retinopathy of prematurity (ROP). Methods. A retrospective study was conducted to screen the nontype 1 ROP from t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haitao Zhang, Xin Yang, Fangfang Zheng, Xiangke Yin, Suhua Wan
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2022/6266528
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
by: Xuting Chen, et al.
Published: (2019-01-01)

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
by: Ahmad M. Mansour, et al.
Published: (2014-01-01)

Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
by: Yu Xu, et al.
Published: (2016-01-01)

Effect and factors associated with reactivation after intravitreal conbercept or aflibercept in retinopathy of prematurity
by: Chunling Huang, et al.
Published: (2025-01-01)

Fluorescein Angiographic Findings of Peripheral Retinal Vasculature after Intravitreal Conbercept versus Ranibizumab for Retinopathy of Prematurity
by: Enzhong Jin, et al.
Published: (2019-01-01)

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
by: Ilias Zampros, et al.
Published: (2012-01-01)

The Effect of Antivascular Endothelial Growth Factor on the Development of Adhesion Formation in Laparotomized Rats: Experimental Study
by: Murat Basbug, et al.
Published: (2011-01-01)

Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity
by: Simona Delia Nicoară, et al.
Published: (2015-01-01)

Is It Safe to Restart Antivascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma after Cardiac Ischemia?
by: Bo Zhao, et al.
Published: (2015-01-01)

Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection
by: Chen Zou, et al.
Published: (2018-01-01)

Intravitreal Bevacizumab Injection Attenuates Diabetic Retinopathy in Adult Rats with Experimentally Induced Diabetes in the Early Stage
by: Jiao Lv, et al.
Published: (2018-01-01)

Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation
by: Mengzhen Xie, et al.
Published: (2024-01-01)

Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema
by: Ningxin Dou, et al.
Published: (2021-01-01)

Analysis of Salivary Cytokines in Retinopathy of Prematurity
by: Hwa-Shiu Wu, et al.
Published: (2025-01-01)

Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema
by: Yanxia Zhu, et al.
Published: (2022-01-01)

Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis
by: Xiaobei Yin, et al.
Published: (2022-01-01)

Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy
by: Jingyuan Yang, et al.
Published: (2019-01-01)

Chinese Herbal Medicine Combined with Intravitreal Antivascular Growth Factor Agents in Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis
by: Su Xiaojuan, et al.
Published: (2022-01-01)

Early applicability of retinopathy of prematurity score (ROPScore) and serum insulin growth factor-1 (IGF-1) for predicting treatment-requiring retinopathy of prematurity: a prospective cohort study
by: Aliaa Adel Ali, et al.
Published: (2025-01-01)

Persistence of Retinopathy of Prematurity in an Infant with Tetralogy of Fallot
by: Murat Gunay, et al.
Published: (2016-01-01)

Retracted: Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema
by: Emergency Medicine International
Published: (2024-01-01)

Randomized Clinical Trial of Intraocular Pressure-Lowering Medications on Preventing Spikes in Intraocular Pressure Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections
by: Piriya Soomsawasdi, et al.
Published: (2024-12-01)

Sterile Endophthalmitis after Intravitreal Injections
by: Joaquín Marticorena, et al.
Published: (2012-01-01)

Bilateral Intravitreal Ranibizumab Injection and Panretinal Photocoagulation in a 16-Year-Old Girl with Severe Vaso-Occlusive Lupus Retinopathy
by: Hasan Can Doruk, et al.
Published: (2013-01-01)

Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
by: J. Fernando Arevalo, et al.
Published: (2011-01-01)

The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi)
by: Paul T. King, et al.
Published: (2015-01-01)

Erratum to “Sterile Endophthalmitis after Intravitreal Injections”
by: Joaquín Marticorena, et al.
Published: (2013-01-01)

Effect of Music on Patient Experience during Intravitreal Injection
by: Jonathan Cheuk-hung Chan, et al.
Published: (2020-01-01)

Severe Presentation of Nontypeable Haemophilus influenzae (NTHi) Infection in a Previously Healthy Toddler
by: Eiman Al Boloushi, et al.
Published: (2019-01-01)

Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up
by: Simon Javidi, et al.
Published: (2020-01-01)

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
by: P. ET. Lau, et al.
Published: (2018-01-01)

Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy
by: Hui-Jin Chen, et al.
Published: (2019-01-01)

Abnormal Expression of Peripheral Blood Leukocyte Surface Markers in Retinopathy of Prematurity Patients
by: Guo R, et al.
Published: (2025-02-01)

Macular Findings Obtained by Spectral Domain Optical Coherence Tomography in Retinopathy of Prematurity
by: Muhammet Kazim Erol, et al.
Published: (2014-01-01)

Mobile model of ophthalmological care for children with retinopathy of prematurity in the southern region of Ukraine
by: Sergii Katsan, et al.
Published: (2024-07-01)

Identification of Iron Homeostasis Genes Dysregulation Potentially Involved in Retinopathy of Prematurity Pathogenicity by Microarray Analysis
by: Xian-qiong Luo, et al.
Published: (2015-01-01)

Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
by: Jianbo He, et al.
Published: (2015-01-01)

Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy
by: Byung Ju Jung, et al.
Published: (2019-01-01)

Changes in Aqueous Humor Cytokine Profile Following Intravitreal Brolucizumab Injection
by: Ruamviboonsuk V, et al.
Published: (2025-02-01)

Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye?
by: Wei Xu, et al.
Published: (2019-01-01)